Tag: Criticism
Expanding Access to HIV Prevention Drug: ViiV Faces Criticism
ViiV Healthcare recently announced plans to increase access to its HIV prevention medication in low- and middle-income countries. This marks the second time in...
BREAKING NEWS
Bluebird Bio Sold to Carlyle, SK Capital for Under $30M
Bluebird Bio, a once-promising biotech company, made headlines recently with its decision to sell itself and its portfolio of gene therapies to investment firms...
